Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Drug delivery

Novel method could help develop new treatments that cross the blood–brain barrier

Researchers have developed a platform that allows them to study the opening and closing of the blood-brain barrier (BBB) in real-time.

The team says the method, which works with cultured cells, could help to design new treatments that can cross the BBB while preventing damage to healthy cells.

The system they have developed uses simultaneous electrical, optical and pressure-based measurements to provide real-time information on the effect of a microbubble and ultrasound technique to open the BBB.

This microbubble-based approach to surmounting the BBB is already being used in clinical trials. It works by injecting microbubbles into the bloodstream and then, by applying ultrasound, the blood-brain barrier can be opened at specific locations to deliver targeted treatment to the brain. But the researchers hope their platform will provide more detailed information on its biological effects.

“The treatment can be monitored externally by ‘listening’ to the re-radiated sound from the cavitation agents interacting with the ultrasound field,” explains researcher Miles Aron, who presented the work[1] at the Acoustics ’17 conference in Boston, Massachusetts.

“These acoustic emissions provide information regarding the energy of cavitation within the blood vessels and are already being used to adjust ultrasound parameters in real time to reduce the likelihood of damaging healthy cells during treatment.”

The researchers say their method, which works like a blood-brain barrier “on a chip”, could be used to screen cavitation agents, such as microbubbles, as well as therapeutics.

The team, based at the Institute of Biomedical Engineering at Oxford University, is currently using the platform to test new treatments for brain diseases and cancer.

“To bring these new techniques to the clinic, we will use our in vitro platform to guide our design and to choose the most promising approaches for animal studies and eventually clinical trials,” says Aron.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203063

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • cultured cells in petri dish

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.